Article
Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals.
Disease markers - 1 Jan 2019
Sakamoto Yuki, Oniki Kentaro, Kumagae Naoki, Morita Kazunori, Otake Koji, Ogata Yasuhiro, Saruwatari Junji
Abstract excerpt
Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases. Obesity is the most common and well-established risk factor for NAFLD, but there are large interindividual differences in the relationship between weight status and the development of NAFLD. Beta-3-adrenergic receptor (ADRB3) plays a key role in the development of visceral obesity and insulin resistance; however, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
